Neurociencia del consumo y dependencia de sustancias psicoactivas
Neurociencia del consumo y dependencia de sustancias psicoactivas Neurociencia del consumo y dependencia de sustancias psicoactivas
7. CUESTIONES ÉTICAS EN LA INVESTIGACIÓN NEUROCIENTÍFICA DEL TRATAMIENTO Y PREVENCIÓN DE LAS FARMACODEPENDENCIASAnon (2001) The tightening grip of big pharma. Lancet, 357:1141.Anthony JC, Helzer J (1991) Syndromes of drug abuse and dependence. In:Robins LN, Regier DA, eds. Psychiatric disorders in America. Nueva York, NY,EE.UU. Academic Press: 116–154.Ashcroft R (2001) Selection of human research subjects. En: Chadwick R, Ed.The concise encyclopedia of the ethics of new technologies. Nueva York, NY, EE.UU.Academic Press: 255–266.Beauchamp TL, Childress JF (2001) Principles of biomedical ethics. Oxford,Inglaterra, Oxford University Press.Brody BA (1998) The ethics of biomedical research: an international perspective.Oxford, Inglaterra, Oxford University Press.Carrera MR y colab. (1995) Suppression of psychoactive effects of cocaine byactive immunization. Nature, 378:727–730.Carrera MR y colab. (2000) Cocaine vaccines: antibody protection againstrelapse in a rat model. Proceedings of the National Academy of Sciences of theUnited States of America, 97:6202–6206.Cochrane AL (1972) Effectiveness and efficiency: random reflections on health services.Abingdon, Berkshire, Inglaterra, Nuffield Provincial Hospitals Trust.Cohen PJ (1997) Immunization for prevention and treatment of cocaine abuse:legal and ethical implications. Drug and Alcohol Dependence, 48:167–174.Cohen PJ (2000) No more kicks. New Scientist, 166:23–36.Cornblatt BA, Lencz T, Kane JM (2001) Treatment of the schizophrenia prodrome:is it presently ethical? Schizophrenia Research, 51:31–38.Davidoff F y colab. (2001) Sponsorship, authorship, and accountability. NewEngland Journal of Medicine, 345:825–827.de Angelis CD, Fontanarosa PB, Flanagin A (2001) Reporting financial conflictsof interest and relationships between investigators and research sponsors. Journalof the American Medical Association, 286:89–91.de Grazia D (2001) Ethical issues in early-intervention clinical trials involvingminors at risk for schizophrenia. Schizophrenia Research, 51:77–86.Dolan K (1996) HIV risk behaviour of IDUs before, during and after imprisonmentin New South Wales. Addiction Research, 4:151–160.Fergusson DM, Horwood LJ (2000) Cannabis use and dependence in a NewZealand birth cohort. New Zealand Medical Journal, 113:156–158.Fox BS (1997) Development of a therapeutic vaccine for the treatment ofcocaine addiction. Drug and Alcohol Dependence, 48:153–158.Fox BS y colab. (1996) Efficacy of a therapeutic cocaine vaccine in rodent models.Nature Medicine, 2:1129–1132.Fox RG (1992) The compulsion of voluntary treatment in sentencing. CriminalLaw Journal, 16:37–54.Fu CH, McGuire PK (1999) Functional neuroimaging in psychiatry.Philosophical Transactions of the Royal Society of London (Series B: BiologicalSciences), 354:1359–1370.237
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASGeneral Accounting Office (1995) Drug courts: information on a new approach toaddress drug-related crime. Washington, DC, EE.UU. Oficina de ContraloríaGeneral de Estados Unidos.Gerstein DR, Harwood HJ (1990) Treating drug problems. Vol. 1. A study of effectivenessand financing of public and private drug treatment systems. Washington,DC, National Academy Press.Gilman S (1998) Imaging the brain: first of two parts. New England Journal ofMedicine, 338:812–820.Gorelick D y colab. (1999) Clinical research in substance abuse: human subjects issues.In: Pincus HA y colab., eds. Ethics in psychiatric research: a resource manual for humansubjects protection. Washington, DC, American Psychiatric Association: 177–218.Gostin LO (1991) Compulsory treatment for drug-dependent persons: justificationsfor a public health approach to drug dependency. Milbank Quarterly,69:561–593.Gostin LO, Mann JM (1999) Toward the development of a human rights impactassessment for the formulation and evaluation of public health policies. En:Mann JM y colab., eds. Health and human rights: a reader. Londres, Inglaterra,Routledge: 54–71.Hall W (1997) The role of legal coercion in the treatment of offenders with alcoholand heroin problems. Australian and New Zealand Journal of Criminology,30:103–120.Hall W, Sannibale C (1996) Are there two types of alcoholism? Lancet, 348:1258.Hall W, Carter L (2002) Ethical and policy issues in trialing and using a cocainevaccine to treat and prevent cocaine dependence. Boletín de la OrganizaciónMundial de la Salud, (en impresión).Heath AC (1995) Genetic influences on alcoholism risk: a review of adoptionand twin studies. Alcohol Health and Research World, 19:166–171.Hjern A, Lindblad F, Vinnerljung B (2002) Suicide, psychiatric illness, andsocial maladjustment in intercountry adoptees in Sweden: a cohort study. Lancet,360:443–448.Horton R (1997) Medical editors trial amnesty. Lancet, 350:756.Hser YI y colab. (2001) A 33-year follow up of narcotic addicts. Archives ofGeneral Psychiatry, 58:503–508.Inciardi JA, McBride DC (1991) Treatment alternatives to street crime: history,experiences and issues. Rockville, MD, Instituto Nacional de Abuso de Drogas deEE.UU.Federación Internacional de la Cruz Roja, Sociedades de la Luna Roja y CentroFrancois-Xavier Bagnoud para la Salud y Derechos Humanos (1999)Introducción a los Derechos Humanos. En: Mann JM y colab., eds. Health andhuman rights: a reader. Londres, Inglaterra, Routledge: 21–28.Johnson MW, Ettinger RH (2000) Active cocaine immunization attenuates thediscriminative properties of cocaine. Experimental and ClinicalPsychopharmacology, 8:163–167.Jonsen AR (1998) The birth of bioethics. Oxford, Inglaterra, Oxford University Press.238
- Page 208 and 209: 6. TRASTORNOS CONCURRENTESFunción
- Page 210 and 211: 6. TRASTORNOS CONCURRENTESRECUADRO
- Page 212 and 213: 6. TRASTORNOS CONCURRENTEStos psiqu
- Page 214 and 215: 6. TRASTORNOS CONCURRENTESCarol G y
- Page 216 and 217: 6. TRASTORNOS CONCURRENTESdepressio
- Page 218 and 219: 6. TRASTORNOS CONCURRENTESHall RG y
- Page 220 and 221: 6. TRASTORNOS CONCURRENTESKapur S,
- Page 222 and 223: 6. TRASTORNOS CONCURRENTESMansvelde
- Page 224 and 225: 6. TRASTORNOS CONCURRENTESPetty F (
- Page 226 and 227: 6. TRASTORNOS CONCURRENTESSevy S y
- Page 228: 6. TRASTORNOS CONCURRENTESlesions o
- Page 231 and 232: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 233 and 234: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 235 and 236: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 237 and 238: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 239 and 240: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 241 and 242: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 243 and 244: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 245 and 246: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 247 and 248: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 249 and 250: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 251 and 252: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 253 and 254: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 255 and 256: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 257: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 261 and 262: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 263 and 264: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 265 and 266: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 267 and 268: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 269 and 270: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 272 and 273: Índice AnalíticoNota: los número
- Page 274 and 275: ÍNDICE ANALÍTICOAtropina 103ATV,
- Page 276 and 277: ÍNDICE ANALÍTICOpolíticas de sal
- Page 278 and 279: ÍNDICE ANALÍTICOuso de tabaco 171
- Page 280 and 281: ÍNDICE ANALÍTICOInmunoterapias pa
- Page 282 and 283: ÍNDICE ANALÍTICOParkinson, efecto
- Page 284 and 285: ÍNDICE ANALÍTICOSolventes voláti
- Page 286: Neurociencia del consumo y dependen
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASGeneral Accounting Office (1995) Drug courts: information on a new approach toaddress drug-related crime. Washington, DC, EE.UU. Oficina <strong>de</strong> ContraloríaGeneral <strong>de</strong> Estados Unidos.Gerstein DR, Harwood HJ (1990) Treating drug problems. Vol. 1. A study of effectivenessand financing of public and private drug treatment systems. Washington,DC, National Aca<strong>de</strong>my Press.Gilman S (1998) Imaging the brain: first of two parts. New England Journal ofMedicine, 338:812–820.Gorelick D y colab. (1999) Clinical research in substance abuse: human subjects issues.In: Pincus HA y colab., eds. Ethics in psychiatric research: a resource manual for humansubjects protection. Washington, DC, American Psychiatric Association: 177–218.Gostin LO (1991) Compulsory treatment for drug-<strong>de</strong>pen<strong>de</strong>nt persons: justificationsfor a public health approach to drug <strong>de</strong>pen<strong>de</strong>ncy. Milbank Quarterly,69:561–593.Gostin LO, Mann JM (1999) Toward the <strong>de</strong>velopment of a human rights impactassessment for the formulation and evaluation of public health policies. En:Mann JM y colab., eds. Health and human rights: a rea<strong>de</strong>r. Londres, Inglaterra,Routledge: 54–71.Hall W (1997) The role of legal coercion in the treatment of offen<strong>de</strong>rs with alcoholand heroin problems. Australian and New Zealand Journal of Criminology,30:103–120.Hall W, Sannibale C (1996) Are there two types of alcoholism? Lancet, 348:1258.Hall W, Carter L (2002) Ethical and policy issues in trialing and using a cocainevaccine to treat and prevent cocaine <strong>de</strong>pen<strong>de</strong>nce. Boletín <strong>de</strong> la OrganizaciónMundial <strong>de</strong> la Salud, (en impresión).Heath AC (1995) Genetic influences on alcoholism risk: a review of adoptionand twin studies. Alcohol Health and Research World, 19:166–171.Hjern A, Lindblad F, Vinnerljung B (2002) Suici<strong>de</strong>, psychiatric illness, andsocial maladjustment in intercountry adoptees in Swe<strong>de</strong>n: a cohort study. Lancet,360:443–448.Horton R (1997) Medical editors trial amnesty. Lancet, 350:756.Hser YI y colab. (2001) A 33-year follow up of narcotic addicts. Archives ofGeneral Psychiatry, 58:503–508.Inciardi JA, McBri<strong>de</strong> DC (1991) Treatment alternatives to street crime: history,experiences and issues. Rockville, MD, Instituto Nacional <strong>de</strong> Abuso <strong>de</strong> Drogas <strong>de</strong>EE.UU.Fe<strong>de</strong>ración Internacional <strong>de</strong> la Cruz Roja, Socieda<strong>de</strong>s <strong>de</strong> la Luna Roja y CentroFrancois-Xavier Bagnoud para la Salud y Derechos Humanos (1999)Introducción a los Derechos Humanos. En: Mann JM y colab., eds. Health andhuman rights: a rea<strong>de</strong>r. Londres, Inglaterra, Routledge: 21–28.Johnson MW, Ettinger RH (2000) Active cocaine immunization attenuates thediscriminative properties of cocaine. Experimental and ClinicalPsychopharmacology, 8:163–167.Jonsen AR (1998) The birth of bioethics. Oxford, Inglaterra, Oxford University Press.238
Change language